New
Helomics
The AI engine Fit Assessment
BetaThe company delivers oncology drug discovery technologies including AI + biobank solutions, tumor profiling, and genomic biomarker testing, and operates a CLIA-certified laboratory supporting pharmaceutical research, indicating strong pharma tech capabilities and partnerships with biopharma.
Blurb
Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.
HQ Location
Pittsburgh (United States)
Founded
1995
Employees
51 - 200
Total funding raised
$211.50M
Funding Status
Corporate Round, December 19, 2017
Please follow us on LinkedIn at https://www.linkedin.com/company/predictive-oncology.
Helomics® is now part of Predictive Oncology, which is headquartered in Pittsburgh, Pennsylvania, and maintains a state-of-the-art research laboratory dedicated to oncology drug discovery and a CLIA-certified clinical laboratory.